Polaryx Therapeutics, Inc. Compensation and benefits remained flat by 0.0% to $21.00K in Q1 2026 compared to the prior quarter.
Significant increases may reflect higher headcount, increased compensation, or timing differences in bonus payouts, while decreases could signal cost-cutting or reduced workforce.
This includes short-term obligations to employees, such as accrued wages, bonuses, vacation pay, and other benefits due...
Commonly reported by labor-intensive companies, particularly in services and logistics.
current_liabilities_employee_related_liabilities_current| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $21.00K | $21.00K |
| QoQ Change | — | +0.0% |